+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Semi-synthetic ß-lactam Antibiotics Market - Global Forecast 2025-2030- Product Image
Semi-synthetic ß-lactam Antibiotics Market - Global Forecast 2025-2030- Product Image
Sale

Semi-synthetic ß-lactam Antibiotics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6079775
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The semi-synthetic β-lactam antibiotics market is evolving quickly, driven by scientific advancement and growing antimicrobial resistance challenges. Senior decision-makers face a dynamic landscape, shaped by innovation, regulatory change, and shifting global supply chain factors.

Market Snapshot: Semi-Synthetic β-lactam Antibiotics

The global semi-synthetic β-lactam antibiotics market serves as a critical arena for pharmaceutical innovation, with stakeholders increasingly focusing on solutions to complex resistance patterns and the demand for broad-spectrum efficacy. Recent advances in medicinal chemistry and rapid assay technologies are facilitating the development of next-generation carbapenems, cephalosporins, monobactams, and penicillins. Cross-industry collaboration between academia, industry leaders, and regulators is streamlining development and approval pathways, resulting in more agile responses to clinical and commercial needs.

Scope & Segmentation

This report provides detailed analysis by product, administration route, end users, distribution channel, and medical indications, along with in-depth coverage of major regions.

  • Product Types: Carbapenem derivatives (including doripenem, ertapenem, imipenem, meropenem), cephalosporin derivatives (classified by generation: first, second, third, fourth), monobactam derivatives such as aztreonam, and penicillin derivatives encompassing amoxicillin, ampicillin, cloxacillin, and oxacillin.
  • Routes of Administration: Oral forms (capsules, suspensions, tablets) supporting outpatient and adherence strategies; parenteral administrations (intramuscular, intravenous) for severe and hospital-acquired infections.
  • End Users: Clinics (general and specialty), hospitals (government and private), and home healthcare providers (including home nursing and self-administered care).
  • Distribution Channels: Hospital pharmacies (contract and in-house), online pharmacies (direct-to-consumer, e-pharmacy), and retail pharmacies (chain and independent).
  • Indications: Covering respiratory infections (community-acquired and lower/upper tract), skin and soft tissue infections (cellulitis, wound management), and urinary tract infections (cystitis, pyelonephritis).
  • Geographic Coverage: Americas (with focus on the United States and select states including California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; as well as Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including leading economies and emerging markets), and Asia-Pacific (key countries like China, India, Japan, Australia, South Korea, Southeast Asian markets).
  • Industry Players: Assesses strategies and developments from companies such as Pfizer Inc., Merck & Co., Inc., GlaxoSmithKline plc, Johnson & Johnson, Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Viatris Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy's Laboratories Ltd., and Cipla Limited.

Key Takeaways

  • Industry innovation is concentrated on structure-guided molecular design and derivative optimization, aiming to counteract bacterial resistance and extend spectrum of activity.
  • Emergence of alternative formulations and long-acting dosing strategies is expanding use settings beyond traditional inpatient environments, creating new opportunities in ambulatory and home care.
  • Collaborative models with biotech firms and contract development organizations are critical to accelerate clinical milestones and share risk.
  • Regional market differences require tailored go-to-market strategies and partnerships responsive to local policies, stewardship programs, and infrastructure capabilities.
  • Digital solutions for adherence and pharmacovigilance are increasingly integrated to support value-based care and differentiate offerings.

Tariff Impact

The imposition of United States tariffs in 2025 introduced immediate supply chain cost pressures, particularly for imported core β-lactam raw materials. In response, manufacturers prioritized domestic production investments and sought long-term agreements to manage supply stability and pricing sustainability. This trade environment prompted a strategic pivot towards enhancing onshore manufacturing agility and reevaluating supplier relationships to safeguard against future disruptions.

Methodology & Data Sources

This report adopts a multi-phase research methodology integrating primary interviews with executives, clinicians, and regulatory experts, along with comprehensive secondary research across peer-reviewed journals, regulatory filings, and clinical trial databases. Patent and chemical synthesis records inform on pipeline trends, while trade data clarifies shifts in supply chain and cost structures. Analytical frameworks such as SWOT, Porter’s Five Forces, and value chain mapping deliver actionable insights.

Semi-Synthetic β-lactam Antibiotics Market: Why This Report Matters

  • Equips senior leaders with precise segmentation and actionable intelligence for strategy, product development, and market entry or expansion in the semi-synthetic β-lactam antibiotics space.
  • Highlights relevant trends in formulation innovation, partnership models, and regulatory engagement, enabling forward-looking investment and collaboration planning.
  • Assists in risk mitigation through analysis of supply chain dynamics, trade disruptions, and regional policy environments.

Conclusion

This report delivers a thorough, segmented understanding of the semi-synthetic β-lactam antibiotics market, highlighting innovation, supply strategies, and regional growth levers. Decision-makers can leverage these strategic insights to optimize readiness for ongoing market shifts and evolving clinical demands.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of novel carbapenem-ß-lactamase inhibitor combinations to combat resistant Gram-negative infections
5.2. Growing adoption of extended-spectrum cephalosporins optimized for community-acquired and hospital-acquired infections
5.3. Increasing investment in enzymatic degradation-resistant penicillin derivatives for severe multidrug-resistant strains
5.4. Expansion of oral ß-lactam prodrugs enhancing inpatient-to-outpatient therapy transition and patient compliance
5.5. Regulatory acceleration pathways and incentives driving research and development of new semi-synthetic ß-lactam molecules
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Semi-synthetic ß-lactam Antibiotics Market, by Product Type
8.1. Introduction
8.2. Carbapenem Derivatives
8.2.1. Doripenem
8.2.2. Ertapenem
8.2.3. Imipenem
8.2.4. Meropenem
8.3. Cephalosporin Derivatives
8.3.1. First Generation Cephalosporins
8.3.2. Fourth Generation Cephalosporins
8.3.3. Second Generation Cephalosporins
8.3.4. Third Generation Cephalosporins
8.4. Monobactam Derivatives
8.4.1. Aztreonam
8.5. Penicillin Derivatives
8.5.1. Amoxicillin
8.5.2. Ampicillin
8.5.3. Cloxacillin
8.5.4. Oxacillin
9. Semi-synthetic ß-lactam Antibiotics Market, by Route of Administration
9.1. Introduction
9.2. Oral
9.2.1. Capsules
9.2.2. Suspensions
9.2.3. Tablets
9.3. Parenteral
9.3.1. Intramuscular
9.3.2. Intravenous
10. Semi-synthetic ß-lactam Antibiotics Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. General Clinics
10.2.2. Specialty Clinics
10.3. Home Healthcare
10.3.1. Home Nursing Services
10.3.2. Self Administered
10.4. Hospitals
10.4.1. Government Hospitals
10.4.2. Private Hospitals
11. Semi-synthetic ß-lactam Antibiotics Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.2.1. Contract Pharmacy
11.2.2. In House Pharmacy
11.3. Online Pharmacies
11.3.1. Direct to Consumer
11.3.2. E Pharmacy Platforms
11.4. Retail Pharmacies
11.4.1. Chain Pharmacies
11.4.2. Independent Pharmacies
12. Semi-synthetic ß-lactam Antibiotics Market, by Indication
12.1. Introduction
12.2. Respiratory Infections
12.2.1. Community Acquired Pneumonia
12.2.2. Lower Respiratory Tract Infection
12.2.3. Upper Respiratory Tract Infection
12.3. Skin and Soft Tissue Infections
12.3.1. Cellulitis
12.3.2. Wound Infections
12.4. Urinary Tract Infections
12.4.1. Cystitis
12.4.2. Pyelonephritis
13. Americas Semi-synthetic ß-lactam Antibiotics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Semi-synthetic ß-lactam Antibiotics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Semi-synthetic ß-lactam Antibiotics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Merck & Co., Inc.
16.3.3. GlaxoSmithKline plc
16.3.4. Johnson & Johnson
16.3.5. Teva Pharmaceutical Industries Ltd.
16.3.6. Sandoz International GmbH
16.3.7. Viatris Inc.
16.3.8. Sun Pharmaceutical Industries Ltd.
16.3.9. Dr. Reddy's Laboratories Ltd.
16.3.10. Cipla Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET: RESEARCHAI
FIGURE 26. SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET: RESEARCHCONTACTS
FIGURE 28. SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CARBAPENEM DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CARBAPENEM DERIVATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DORIPENEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DORIPENEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ERTAPENEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ERTAPENEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY IMIPENEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY IMIPENEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY MEROPENEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY MEROPENEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CARBAPENEM DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CARBAPENEM DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN DERIVATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY FIRST GENERATION CEPHALOSPORINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY FIRST GENERATION CEPHALOSPORINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY FOURTH GENERATION CEPHALOSPORINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY FOURTH GENERATION CEPHALOSPORINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SECOND GENERATION CEPHALOSPORINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SECOND GENERATION CEPHALOSPORINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY THIRD GENERATION CEPHALOSPORINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY THIRD GENERATION CEPHALOSPORINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY MONOBACTAM DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY MONOBACTAM DERIVATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY AZTREONAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY AZTREONAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY MONOBACTAM DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY MONOBACTAM DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PENICILLIN DERIVATIVES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PENICILLIN DERIVATIVES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY AMOXICILLIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY AMOXICILLIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY AMPICILLIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY AMPICILLIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CLOXACILLIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CLOXACILLIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY OXACILLIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY OXACILLIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PENICILLIN DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PENICILLIN DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CAPSULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CAPSULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SUSPENSIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY TABLETS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY TABLETS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOME NURSING SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOME NURSING SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SELF ADMINISTERED, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CONTRACT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CONTRACT PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY IN HOUSE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY IN HOUSE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DIRECT TO CONSUMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY E PHARMACY PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY E PHARMACY PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CHAIN PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COMMUNITY ACQUIRED PNEUMONIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY LOWER RESPIRATORY TRACT INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY LOWER RESPIRATORY TRACT INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY UPPER RESPIRATORY TRACT INFECTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CELLULITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CELLULITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY WOUND INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY WOUND INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CYSTITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CYSTITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PYELONEPHRITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, 2025-2030 (USD MILLION)
TABLE 153. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 154. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 155. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CARBAPENEM DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 156. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CARBAPENEM DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 157. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 158. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 159. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY MONOBACTAM DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 160. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY MONOBACTAM DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 161. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PENICILLIN DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 162. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PENICILLIN DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 163. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 164. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 165. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 166. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 167. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 168. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 169. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 170. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 171. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 172. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 173. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 174. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 175. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 176. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 195. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 196. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 197. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CARBAPENEM DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 198. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CARBAPENEM DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 199. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 200. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 201. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY MONOBACTAM DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 202. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY MONOBACTAM DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 203. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PENICILLIN DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 204. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PENICILLIN DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 205. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 206. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 207. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 208. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 209. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 210. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 211. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 214. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 215. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 216. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 217. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 218. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 219. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 237. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 238. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 239. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CARBAPENEM DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 240. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CARBAPENEM DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 241. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 242. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CEPHALOSPORIN DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 243. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY MONOBACTAM DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 244. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY MONOBACTAM DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 245. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PENICILLIN DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 246. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PENICILLIN DERIVATIVES, 2025-2030 (USD MILLION)
TABLE 247. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 248. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 249. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ORAL, 2018-2024 (USD MILLION)
TABLE 250. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ORAL, 2025-2030 (USD MILLION)
TABLE 251. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 252. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 253. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 254. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 255. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CLINICS, 2018-2024 (USD MILLION)
TABLE 256. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CLINICS, 2025-2030 (USD MILLION)
TABLE 257. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOME HEALTHCARE, 2018-2024 (USD MILLION)
TABLE 258. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOME HEALTHCARE, 2025-2030 (USD MILLION)
TABLE 259. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 260. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 261. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 262. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 263. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 264. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY HOSPITAL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 265. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACIES, 2018-2024 (USD MILLION)
TABLE 266. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY ONLINE PHARMACIES, 2025-2030 (USD MILLION)
TABLE 267. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACIES, 2018-2024 (USD MILLION)
TABLE 268. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RETAIL PHARMACIES, 2025-2030 (USD MILLION)
TABLE 269. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 270. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 271. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, 2018-2024 (USD MILLION)
TABLE 272. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY RESPIRATORY INFECTIONS, 2025-2030 (USD MILLION)
TABLE 273. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, 2018-2024 (USD MILLION)
TABLE 274. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY SKIN AND SOFT TISSUE INFECTIONS, 2025-2030 (USD MILLION)
TABLE 275. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, 2018-2024 (USD MILLION)
TABLE 276. CANADA SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY URINARY TRACT INFECTIONS, 2025-2030 (USD MILLION)
TABLE 277. MEXICO SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. MEXICO SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. MEXICO SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS MARKET SIZE, BY CARBAPENEM DERIVATIVES, 2018-2024 (USD MILLION)
TABLE 280. MEXICO SEMI-SYNTHETIC ?-LACTAM ANTIBIOTICS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Semi-synthetic β-lactam Antibiotics market report include:
  • Pfizer Inc.
  • Merck & Co., Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Teva Pharmaceutical Industries Ltd.
  • Sandoz International GmbH
  • Viatris Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Dr. Reddy's Laboratories Ltd.
  • Cipla Limited

Related Topics

Related Reports

Antibacterial Drugs - Global Strategic Business Report - Product Image

Antibacterial Drugs - Global Strategic Business Report

  • Report
  • 244 Pages
  • Global
From
EU - Antibiotics - Market Analysis, Forecast, Size, Trends and Insights - Product Image

EU - Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

  • Report
  • Europe
From
Antibiotic-Associated Diarrhea Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Antibiotic-Associated Diarrhea Treatment Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Enzymes for ß-lactam Antibiotics Market - Global Forecast 2025-2030 - Product Image

Enzymes for ß-lactam Antibiotics Market - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Antibiotics Market - Global Forecast 2025-2032 - Product Image

Antibiotics Market - Global Forecast 2025-2032

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.